Sort
82,697 grants matching “vaccine development”
Vaccine Treatment Evaluation Units: Infectious Diseases Clinical ResearchConsortium
$5,485,854Karen L. Kotloff · University Of Maryland Baltimore · UM1 · FY2020 · AI
Vaccine and Treatment Evaluation Units
$5,485,363Nadine Georges Rouphael · Emory University · UM1 · FY2020 · AI
Advancement of Treatments for Ebola and Marburg Virus Infections
$5,485,257Thomas William Geisbert · University Of Texas Med Br Galveston · U19 · FY2016 · AI
Pandemic Influenza Translational Research and Novel Drug Therapy
$5,482,833Matthew Memoli · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Indiana Clinical and Translational Sciences Institute
$5,474,745Sharon M Moe · Indiana University Indianapolis · UM1 · FY2023 · TR
CORE NICHD NETWORK CLINICAL SITE SUPPORT FOR IMPAACT RELATED STUDIES
$5,474,227Barbara Driver · Westat, Inc. · N01 · FY2024 · HD
Innovative Platforms for Antimicrobial Therapy and Vaccine Development
$5,474,214Dennis L. Kasper · Harvard Medical School · U19 · FY2016 · AI
Pathogenesis And Treatment Of Aplastic Anemia
$5,469,242Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2009 · HL
The Malawi Clinical Trials Unit
$5,464,755Taha E Taha · Johns Hopkins University · UM1 · FY2012 · AI
B-cell Biology of Mucosal Immune Protection from SIV Challenge
$5,457,454Eric Hunter · Emory University · U19 · FY2011 · AI
SURGERY, IMMUNOLOGY AND IMMUNOTHERAPY OF HUMAN CANCER
$5,456,450John Wayne Cancer Institute · P01 · FY2005 · CA
Delaney AIDS Research Enterprise to Cure HIV
$5,455,521Steven Grant Deeks · University Of California, San Francisco · UM1 · FY2024 · AI
Delaney AIDS Research Enterprise to Cure HIV
$5,452,430Steven Grant Deeks · University Of California, San Francisco · UM1 · FY2023 · AI
Implementation and Real-World Effectiveness of Monoclonal Antibodies to Treat High-Risk Outpatients with COVID-19
$5,449,454Ronald J Sokol · University Of Colorado Denver · UL1 · FY2021 · TR
Delaney AIDS Research Enterprise to Cure HIV
$5,448,894Steven Grant Deeks · University Of California, San Francisco · UM1 · FY2022 · AI
Immune Mechanisms of Protection Against Mycobacterium Tuberculosis Center (IMPAC-TB)
$5,443,065Kevin Urdahl · Seattle Children'S Hospital · N01 · FY2024 · AI
The Malawi Clinical Trials Unit
$5,442,439Taha E Taha · Johns Hopkins University · U01 · FY2007 · AI
NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Research Activities
$5,442,435Walter Orenstein · Emory University · N01 · FY2023 · AI
SDMC: HIV Vaccine Trials Network
$5,436,127Peter B. Gilbert · Fred Hutchinson Cancer Research Center · UM1 · FY2022 · AI
Characterizing pediatric genomes through an optimized sequencing approach
$5,427,005Shawn E Levy · Hudson-Alpha Institute For Biotechnology · U24 · FY2019 · HD
Indiana Clinical and Translational Sciences Institute
$5,426,574Sharon M Moe · Indiana University Indianapolis · UM1 · FY2024 · TR
Evaluation of Optimized Lead Candidates for Encephalitic Alphaviruses in Animal Models
$5,425,184Colleen B Jonsson · University Of Tennessee Health Sci Ctr · U19 · FY2023 · AI
Harnessing CD4+ T cell responses for long-term protective immunity against HIV
$5,422,968Rafi Ahmed · Scripps Research Institute, The · UM1 · FY2015 · AI
Assays to Support Development of Malaria Transmission Blocking Vaccines
$5,422,499Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Protective human antibodies for picornaviruses
$5,421,688Matthew R Vogt · Vanderbilt University Medical Center · U19 · FY2024 · AI